At Roche, we are committed to providing Canadians with innovative medicines to improve their health and quality of life. We focus on areas of significant unmet medical need and areas where we have the expertise to make a difference.
From our early days as a developer of neuropsychology, specialty antibiotics and anti-inflammatory drugs, we have a history of transcending conventional boundaries to deliver new treatment options and redefine the standard of care. Our personalized healthcare strategy seeks to tailor disease management to the individual patient, to improve patient outcomes and better use our healthcare resources. Today, we offer treatment options in oncology, neurosciences, rare diseases, immunology, infectious diseases, hematology, hemophilia, and respiratory diseases.
We strongly believe in creating value through innovation and increasing the effectiveness and efficiency of the healthcare system by partnering with healthcare providers, as well as institutions. At Roche, driving access to medicines is critical to our mission of doing now what patients need next. This understanding of our broader role within the healthcare system informs our approach to business and ensuring that every person who needs our medicines is able to access, as well as benefit from them through our Patient Assistance Programs.